MMMomtaz Thabet Allam Mohammad

Momtaz Thabet Allam Mohammad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Momtaz Thabet Allam Mohammad has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endothelial dysfunction in children with newly diagnosed Graves’ disease

    by Yasser Gamal, Ahlam Badawy, Ahmed M. Ali, Hekma Saad Farghaly, Kotb Abbass Metwalley, Noha Gaber, Momtaz Thabet Allam, Yasser Farouk

    The most frequent cause of hyperthyroidism in children is Graves’ disease (GD). Vascular endothelium is a specific target of thyroid hormone. The purpose of this study is to assess flow-mediated dilatation (FMD)% and serum von Willebrand factor (vWF) levels in children with newly diagnosed GD to reflect the extent of endothelial dysfunction in those children. In this study, 40 children with newly discovered GD and 40 children who were healthy served as the control group. Both patients and controls had anthropometric assessment, as well as measurements of fasting lipids, glucose, insulin, high-sensitivity C-reactive protein (hs-CRP), TSH, and free thyroxine (FT4 and FT3), thyrotropin receptor antibodies TRAbs and vWF. Noninvasive ultrasound was utilized to quantify the carotid arteries’ intima-media thickness and the brachial artery’s FMD. Patients reported significantly reduced FMD response and greater vWF and hs-CRP levels compared to controls (P = 0.001 for each). In multivariate analysis, we reported that vWF was significantly correlated with TSH (OR 2.5, 95% CI 1.32–5.32, P = 0.001), FT3 (OR 3.4, 95% CI 1.45–3.55, P = 0.001), TRAb (OR 2.1, 95% CI 1.16–2.23, P = 0.01), and FMD% (OR 4.2, 95% CI 1.18–8.23, P = 0.001).  Conclusions: Children with newly diagnosed GD have endothelial dysfunction, which is shown by impaired FMD and increased vWF. These findings support the idea that GD may need to be treated as soon as possible. What is Known:• Graves' disease is the most common cause of hyperthyroidism in children.• vWF is a reliable marker for detection of vascular endothelial dysfunction. What is New:• Children with newly diagnosed Graves' disease may have endothelial dysfunction as reflected by impairment of FMD and raised vWF level.• Measurement of vWF level in children with newly diagnosed Graves' disease can be used for early detection of endothelial dysfunction.


  • Open Access

    Role of Trans-Catheter Prostatic Artery Embolization in Management of Benign Prostatic Hyperplasia

    by Momtaz Thabet Allam Mohammad, Abd Al Kariem Hassan Abd Allah, Moustafa Hashem Mahmoud Othman, Hany Mohammed Abd El Hakeem Seif

    Background: To evaluate the efficacy and safety of prostatic artery embolization as a line of treatment for benign prostatic hyperplasia in patient with moderate to severe lower urinary tract symptoms (LUTS) secondary to BPH after failure of medical treatment. Methods: Twenty patients included in this study and their ages ranged from 43-93 years (mean 68.3 y). All patients complained of moderate to severe LUTS secondary to benign prostatic enlargement. All patients underwent prostatic artery embolization (unilateral n = 5 and bilateral n = 15). The embolizing material used is PVA ranged from (45-250). Patients were followed up using international prostate symptom score (IPSS), prostate volume, quality of life (QOL) and peak flow rate (Qmax). Results: Nineteen patients show IPSS reduction by 0.0-86% (mean 73.68% +/- 16.8), prostate volume reduction by 14.6-41.5% (mean 26.16% +/- 7.8), QOL improvement by 0.0-100% (mean 81.3% +/- 24.34) and Qmax improvement by 36.1-80.5% (mean 62.6% +/- 14.29) after one and three months follow up. Clinical improvement was +/- 95%. One patient shows clinical failure after successful bilateral prostatic artery embolization. No deaths. Minor complications as hematuria and blood in stool occurred in 10% (2 cases) and were self-limited. Conclusions: Prostatic artery embolization is safe and effective line of treatment for patients with moderate to severe LUTS secondary to benign prostatic enlargement after failure of medical treatment. It has low morbidity, good short-term symptomatic control associated with prostate volume reduction and quality of life improvement. Publication Date: 26 April 2021 (online) © 2017. The Arab Journal of Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India